UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000044983 |
|---|---|
| Receipt number | R000050968 |
| Scientific Title | Evaluation of the effect of ginger extract powder on blood flow rate in healthy subjects |
| Date of disclosure of the study information | 2021/07/28 |
| Last modified on | 2022/07/28 10:22:37 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Evaluation of the effect of ginger extract powder on blood flow rate in healthy subjects
Acronym
Evaluation of the effect of ginger extract powder on blood flow rate in healthy subjects
Scientific Title
Evaluation of the effect of ginger extract powder on blood flow rate in healthy subjects
Scientific Title:Acronym
Evaluation of the effect of ginger extract powder on blood flow rate in healthy subjects
Region
| Japan |
Condition
Condition
Healthy
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To assess the effect of ginger extract powder on retinal blood flow
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
8-week change in retinal blood flow
Key secondary outcomes
>8-week changes in the followings: muscle hardness in shoulder, peripheral blood flow rate, visual analogue scales (VAS) for visual fatigue, VAS for shoulder stiffness, VAS for warmth of a body, dioptometry, radius of curvature of the cornea, central corneal thickness, visual acuity, intraocular pressure, and a fundus photo
>The relationship among retinal blood flow, intraocular pressure, and eye stiffness
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
YES
Dynamic allocation
NO
Institution consideration
Blocking
YES
Concealment
No need to know
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Subjects take 1 capsule per day containing 100 mg of ginger extract powder for 8 weeks.
Interventions/Control_2
Subjects take 1 placebo capsule per day for 8 weeks.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 75 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1) Healthy
2) Feeling visual fatigue and shoulder stiffness
Key exclusion criteria
1) Ocular disorder requiring prompt treatment
2) Taking medicines or functional food that may affect the trial
3) Participation in any clinical trial within 90 days of the commencement of the trial
4) In pregnancy or nursing a child
5) Judged as ineligible by the investigators
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Fumiko |
| Middle name | |
| Last name | Higashikawa |
Organization
Graduate School of Biomedical and Health Sciences, Hiroshima University
Division name
Department of Probiotic Science for Preventive Medicine
Zip code
734-8551
Address
Kasumi 1-2-3, Minami-ku, Hiroshima 734-8551, JAPAN
TEL
0822571533
fumiko@hiroshima-u.ac.jp
Public contact
Name of contact person
| 1st name | Fumiko |
| Middle name | |
| Last name | Higashikawa |
Organization
Graduate School of Biomedical and Health Sciences, Hiroshima University
Division name
Department of Probiotic Science for Preventive Medicine
Zip code
734-8551
Address
Kasumi 1-2-3, Minami-ku, Hiroshima 734-8551, JAPAN
TEL
0822571533
Homepage URL
fumiko@hiroshima-u.ac.jp
Sponsor or person
Institute
Hiroshima University
Institute
Department
Personal name
Funding Source
Organization
IKEDA FOOD RESEARCH CO., LTD.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethical Committee for Clinical Research of Hiroshima University
Address
Kasumi 1-2-3 Minami-Ku, Hiroshima 734-8551
Tel
082-257-1551
iryo-seisaku@office.hiroshima-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
広島大学病院（広島県）
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 07 | Month | 28 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2021 | Year | 07 | Month | 20 | Day |
Date of IRB
| 2021 | Year | 07 | Month | 20 | Day |
Anticipated trial start date
| 2021 | Year | 07 | Month | 28 | Day |
Last follow-up date
| 2022 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2021 | Year | 07 | Month | 28 | Day |
Last modified on
| 2022 | Year | 07 | Month | 28 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050968
